Bupropion for smoking cessation in adolescents
Bupropion may help adolescents quit smoking in the short term, but it is not approved for this age group. More research is needed on its long-term effectiveness and safety in young smokers.
Area of Science:
- Adolescent medicine
- Pharmacology
- Public health
Background:
- Adolescent smoking remains a significant public health issue, with high rates of unsuccessful quit attempts.
- Bupropion is a recognized first-line smoking cessation aid for adults.
Purpose of the Study:
- To evaluate the effectiveness and safety of bupropion for smoking cessation in adolescents.
- To address the lack of approved pharmacologic options for adolescent smokers.
Main Methods:
- Review of existing clinical trials and data on bupropion use in adolescent smoking cessation.
- Analysis of adverse events reported in bupropion trials.
Main Results:
- Bupropion shows short-term effectiveness in improving smoking abstinence rates among adolescents.
- No increased adverse events were observed in smoking cessation trials involving bupropion.
Conclusions:
- Bupropion demonstrates potential as a short-term smoking cessation aid for adolescents.
- Further research is required to establish long-term efficacy and safety in this population.
- Bupropion is not currently approved by Health Canada for individuals under 18 years of age.
More Related Videos
14:21Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Drug Dependence
